非小细胞肺癌脑转移高危因素研究进展

Brain metastasis of non-small cell lung cancer (NSCLC) is a common treatment failure mode, and the median survival time of NSCLC patients with brain metastasis is only 1 mon-2 mon.Prophylactic cranial irradiation (PCI) can delay the occurrence of brain metastasis, but the survival benefits of NSCLC...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2022
Materias:
综述
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976204/
https://www.ncbi.nlm.nih.gov/pubmed/35340162
http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.08
Descripción
Sumario:Brain metastasis of non-small cell lung cancer (NSCLC) is a common treatment failure mode, and the median survival time of NSCLC patients with brain metastasis is only 1 mon-2 mon.Prophylactic cranial irradiation (PCI) can delay the occurrence of brain metastasis, but the survival benefits of NSCLC patients are still controversial.It is particularly important to identify the patients who are most likely to benefit from PCI.This article reviews the high risk factors of brain metastasis in NSCLC.

Ejemplares similares